Biological and anatomo-pathological characteristics. How to improve financial items.
Pathologist, Clermont Ferrand, France
New User? Click here to register
Cancer treatment has always been a journey of evolution, with gradual improvements over time. However, the last couple of years have witnessed a remarkable shift – a surge in progress unlike we’ve seen before.
This isn’t just incremental improvement; we’re seeing “little spits of massive advance,” as Georgia DEMETRIOU describes it. The introduction of new therapies like CKD 4/6 inhibitors in the adjuvant setting exemplifies this leap forward. Two drugs within this category have shown promising benefits, marking a significant turning point in treatment strategies.
While these breakthroughs are highly significant, the journey towards effective cancer treatment has always been marked by both rapid advancements and periods of slower progress. The speaker highlights that even small improvements – a “little bit” more survival preparation, a “little bit” more overall survival – accumulate over time, eventually leading to substantial gains.
This analogy paints a vivid picture: small advancements in cancer research and treatment, when added together, create a profound impact on patient outcomes.
Text generated by AI based on an exclusive interview, revised and reviewed by
Jean-Philippe SPANO
Chairman of Oncology department , University hospital Pitié-Salpétrière, Paris, France
Copyright © 2025 - BCU